Valneva (VALN) News Today $11.53 +1.06 (+10.12%) Closing price 08/15/2025 04:00 PM EasternExtended Trading$11.64 +0.11 (+0.95%) As of 08/15/2025 07:45 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock VALN Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Valneva (NASDAQ:VALN) Trading 14.3% Higher Following Strong EarningsAugust 15 at 10:28 AM | marketbeat.comValneva (NASDAQ:VALN) Sets New 1-Year High - Time to Buy?August 15 at 5:32 AM | marketbeat.comA Vaccine for a Mosquito-Borne Disease Fuels Valneva Stock RallyAugust 15 at 4:03 AM | bloomberg.comValneva (NASDAQ:VALN) Shares Gap Up Following Better-Than-Expected EarningsAugust 13 at 10:52 AM | marketbeat.comValneva (NASDAQ:VALN) Announces Quarterly Earnings Results, Beats Estimates By $0.11 EPSAugust 13 at 9:47 AM | marketbeat.comValneva (NASDAQ:VALN) Sees Strong Trading Volume - Time to Buy?August 12, 2025 | marketbeat.comValneva SE 2025 Q2 - Results - Earnings Call PresentationAugust 12, 2025 | seekingalpha.comValneva Shares Gain After Results, OutlookAugust 12, 2025 | marketwatch.comValneva (NASDAQ:VALN) Trading Down 6.7% - Here's What HappenedAugust 12, 2025 | marketbeat.comValneva Reports Half Year 2025 Financial Results and Provides Corporate UpdatesAugust 12, 2025 | globenewswire.comValneva SE (VALN) Q2 2025: Everything You Need To Know Ahead Of EarningsAugust 11, 2025 | finance.yahoo.comValneva (VALN) Expected to Announce Quarterly Earnings on TuesdayAugust 11, 2025 | americanbankingnews.comValneva (NASDAQ:VALN) Hits New 12-Month High - Time to Buy?August 10, 2025 | americanbankingnews.comValneva (NASDAQ:VALN) Hits New 12-Month High - Here's WhyAugust 9, 2025 | marketbeat.comFDA removes Ixchiq partial pause but tightens vaccine’s useAugust 8, 2025 | finance.yahoo.comFDA lifts pause on Valneva's chikungunya vaccine in elderlyAugust 8, 2025 | msn.comFDA lifts pause on Valneva’s chikungunya shot, but adds new limitsAugust 8, 2025 | yahoo.comValneva Announces Removal of FDA-Recommended Pause on Use of Chikungunya Vaccine IXCHIQ® in Elderly and Updates to the Prescribing InformationAugust 7, 2025 | globenewswire.comValneva (VALN) Projected to Post Quarterly Earnings on TuesdayAugust 6, 2025 | marketbeat.comVALNEVA Declaration of shares and voting rights: July 31, 2025August 6, 2025 | finance.yahoo.comValneva (NASDAQ:VALN) Sees Large Volume Increase - Here's WhyJuly 29, 2025 | marketbeat.comAGC Biologics’ Heidelberg Site Supplies Drug Substance for Phase II Studies of Valneva’s Tetravalent Shigella Vaccine CandidateJuly 29, 2025 | finance.yahoo.comValneva (NASDAQ:VALN) Shares Gap Up - Still a Buy?July 25, 2025 | marketbeat.comValneva (NASDAQ:VALN) Shares Up 13.1% - Should You Buy?July 24, 2025 | marketbeat.comValneva (NASDAQ:VALN) Shares Gap Down - Time to Sell?July 21, 2025 | marketbeat.comValneva (NASDAQ:VALN) Shares Gap Up - Here's What HappenedJuly 15, 2025 | marketbeat.comValneva's chikungunya vaccine suspension gets lifted for older adultsJuly 11, 2025 | msn.comValneva Announces Lifting of European Medicines Agency's Temporary Restriction on Use of Chikungunya Vaccine IXCHIQ® in ElderlyJuly 11, 2025 | globenewswire.comEurope lifts restriction on Valneva's chikungunya vaccine for elderly adultsJuly 11, 2025 | reuters.comValneva Announces Exclusive Vaccine Marketing and Distribution Agreement for Germany with CSL SeqirusJune 26, 2025 | globenewswire.comValneva Announces Successful Outcome of its Annual General Meeting, Confirms FY 2025 guidanceJune 25, 2025 | globenewswire.comValneva Scotland earns prestigious global health and safety awardJune 24, 2025 | msn.comValneva (NASDAQ:VALN) Shares Gap Down - Should You Sell?June 17, 2025 | marketbeat.comValneva SE (NASDAQ:VALN) Sees Large Drop in Short InterestJune 14, 2025 | marketbeat.comValneva (NASDAQ:VALN) Stock Price Down 4% - Here's What HappenedJune 12, 2025 | marketbeat.comUK's MHRA suspends Valneva's chikungunya vaccine for elderlyJune 10, 2025 | reuters.comUK restricts use of Valneva chikungunya vaccine for safety reviewJune 10, 2025 | yahoo.comUK's MHRA suspends Valneva's chikungunya vaccine for elderly (June 9)June 10, 2025 | msn.comValneva reports data from Phase II chikungunya vaccine trial in childrenJune 6, 2025 | finance.yahoo.comValneva Reports Positive Six-Month Antibody Persistence and Safety Phase 2 Results in Children for its Single-Shot Chikungunya Vaccine IXCHIQ®June 5, 2025 | globenewswire.comValneva Announces Availability of Documentation for its Combined Shareholder Meeting and Provides Corporate UpdateJune 4, 2025 | globenewswire.comValneva SE (NASDAQ:VALN) Sees Large Decrease in Short InterestJune 2, 2025 | marketbeat.comValneva to Participate at U.S. and European Investor Conferences in JuneMay 26, 2025 | globenewswire.comUS CDC accepts recommendations for chikungunya vaccinesMay 21, 2025 | msn.comU.S. Advises Older Travelers to Avoid Chikungunya VaccineMay 13, 2025 | usnews.comFDA warns seniors to avoid this vaccine after deadly complicationsMay 13, 2025 | msn.com2VALN : US Health Agencies Recommend Pausing Valneva's Chikungunya Vaccine For...May 13, 2025 | benzinga.comWhat Is the Chikungunya Vaccine? CDC Issues Notice to Older TravelersMay 12, 2025 | msn.comUS health officials advise older travelers not to get a chikungunya vaccineMay 12, 2025 | apnews.comAValneva’s chikungunya vaccine use halted in older adults amid safety concernsMay 12, 2025 | finance.yahoo.com Get Valneva News Delivered to You Automatically Sign up to receive the latest news and ratings for VALN and its competitors with MarketBeat's FREE daily newsletter. Email Address VALN Media Mentions By Week VALN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. VALN News Sentiment▼0.350.61▲Average Medical News Sentiment VALN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. VALN Articles This Week▼175▲VALN Articles Average Week Get Valneva News Delivered to You Automatically Sign up to receive the latest news and ratings for VALN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies AMRX News NAMS News XENE News KNSA News RXRX News CNTA News ARWR News IDYA News BHC News BLTE News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:VALN) was last updated on 8/16/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredGenesis 14:13-17 [HIDDEN MEANING?]A mysterious Bible verse from Genesis may hold the key to unlocking what one expert calls an “American birthri...Paradigm Press | SponsoredTrump's New Plan to “Make China Pay”Trump's AI Masterplan Could Crush China The White House just unleashed would could be the most aggressive e...Stansberry Research | SponsoredCover all your expenses with just $118,000 invested?Generate up to $5,000/month with 10X less money? That's what every financial advisor tells you. But I just ...Investors Alley | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Valneva SE Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Valneva With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.